EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Short-Term DAPT After Complex PCI With Third-Generation DES: A Post Hoc Analysis of the HOST-IDEA Trial

Jung-Kyu Han iD, Keehwan Lee, Sang-Hyeon Park iD, Seokhun Yang iD, Doyeon Hwang, Jeehoon Kang, Han-Mo Yang iD, Kyung Woo Park iD, Hyun-Jae Kang iD, Bon-Kwon Koo iD, Seung-Ho Hur iD, Weon Kim iD und 8 weitere

Circulation: Cardiovascular Interventions · 2025

DOI: 10.1161/circinterventions.124.014623 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2025. Verfasst von Jung-Kyu Han und 19 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Center, Seoul National University Hospital, Republic of Korea (J.-K.H., K.L., Sang-Hyeon Park, S.Y., D.H., J.K., H.-M.Y., K.W.P., H.-J…. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Drug-Eluting Stents, Platelet Aggregation Inhibitors, Coronary Artery Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The optimal duration of dual antiplatelet therapy (DAPT) after complex percutaneous coronary intervention (PCI) remains unclear. We aim to investigate the efficacy and safety of 3 to 6 months of DAPT over 12 months after complex PCI. METHODS: A post hoc analysis of the HOST-IDEA (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Coronary Intervention With Next-Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy) randomized trial which enrolled patients undergoing PCI with third-generation drug-eluting stents was performed. Complex PCI was defined by any of the following: ≥3 stents implanted, ≥3 lesions treated, bifurcation PCI with 2-stenting, total stent length ≥60 mm, left main PCI, or heavy calcification. The major end points were target lesion failure, a composite of cardiac death, target vessel myocardial infarction, and clinically driven target lesion revascularization for ischemic outcomes, and major bleeding, defined as BARC (Bleeding Academic Research Consortium) type 3 or 5, for bleeding outcomes at 12 months. RESULTS: Among 1992 patients, 624 underwent complex PCI. The complex PCI group had clinical features associated with high bleeding risk. A shortened DAPT duration did not increase the risk of target lesion failure, with hazard ratios of 0.818 (95% CI, 0.403–1.659) for the complex PCI group and 1.282 (95% CI, 0.506–3.249) for the noncomplex PCI group ( P interaction =0.451). Conversely, it decreased the risk of major bleeding in the complex PCI group (hazard ratio, 0.269 [95% CI, 0.075–0.965]), but not in the noncomplex PCI group (hazard ratio, 1.534 [95% CI, 0.627–3.754], showing a significant interaction; P interaction =0.029). CONCLUSIONS: In patients undergoing complex PCI with a third-generation drug-eluting stent, a 3- to 6-month duration of DAPT was associated with a reduced risk of bleeding without an increased risk of ischemic events compared with 12-month DAPT. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT02601157.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionDrug-Eluting StentsPlatelet Aggregation InhibitorsCoronary Artery DiseaseDual Anti-Platelet TherapyCoronary StenosisHumansMaleFemaleTime FactorsAgedMiddle AgedTreatment OutcomeHemorrhageRisk FactorsDrug Administration ScheduleRisk AssessmentProsthesis Design

Stichwörter der Autor:innen

coronary artery diseasedrug-eluting stentspercutaneous coronary interventionrisk

Substanzen

Platelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Cardiovascular Center, Seoul National University Hospital, Republic of Korea (J.-K.H., K.L., Sang-Hyeon Park, S.Y., D.H., J.K., H.-M.Y., K.W.P., H.-J.K., B.-K.K., H.-S.K.).
  • Department of Internal Medicine, College of Medicine, Seoul National University, Republic of Korea (J.-K.H., H.-M.Y., K.W.P., H.-J.K., B.-K.K., S.-H.K., H.-S.K.).
  • Division of Cardiology, Department of Medicine, Gangneung Asan Hospital, South Korea (K.L.).
  • Department of Internal Medicine, Daejeon Eulji Medical Center, Eulji University School of Medicine, Republic of Korea (Sang-Hyun Park).
  • Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Republic of Korea (S.-H.H.).
  • Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea (W.K.).

ORCID-Profile: Jung-Kyu Han, Sang-Hyeon Park, Seokhun Yang, Han-Mo Yang, Kyung Woo Park, Hyun-Jae Kang, Bon-Kwon Koo, Seung-Ho Hur, Weon Kim, Sang-Hyun Park, Seung Hwan Han, Sang-Hyun Kim, Yong Hoon Kim, Namho Lee, Sanghoon Shin, Hyo-Soo Kim

Zitieren

APA

Han, J. K., Lee, K., Park, S. H., Yang, S., Hwang, D., Kang, J., Yang, H. M., Park, K. W., Kang, H. J., Koo, B. K., Hur, S. H., Kim, W., Park, S. H., Han, S. H., Kim, S. H., Kim, Y. H., Lee, N., Lee, S. J., Shin, S., & Kim, H. S. (2025). Short-Term DAPT After Complex PCI With Third-Generation DES: A Post Hoc Analysis of the HOST-IDEA Trial. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.124.014623

Vancouver

Han JK, Lee K, Park SH, Yang S, Hwang D, Kang J, et al. Short-Term DAPT After Complex PCI With Third-Generation DES: A Post Hoc Analysis of the HOST-IDEA Trial. Circulation: Cardiovascular Interventions. 2025. doi:10.1161/circinterventions.124.014623

BibTeX
@article{Han2025,
  author = {Han, Jung-Kyu and Lee, Keehwan and Park, Sang-Hyeon and Yang, Seokhun and Hwang, Doyeon and Kang, Jeehoon and Yang, Han-Mo and Park, Kyung Woo and Kang, Hyun-Jae and Koo, Bon-Kwon and Hur, Seung-Ho and Kim, Weon and Park, Sang-Hyun and Han, Seung Hwan and Kim, Sang-Hyun and Kim, Yong Hoon and Lee, Namho and Lee, Seung Jin and Shin, Sanghoon and Kim, Hyo-Soo},
  title = {Short-Term DAPT After Complex PCI With Third-Generation DES: A Post Hoc Analysis of the HOST-IDEA Trial},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1161/circinterventions.124.014623}
}
Kostenlos starten →